Monographie - Pentostatin - Stabilis 4.0

2017-09-06 2020-10-14 3 FULL PRESCRIBING INFORMATION 1. INDICATIONS AND USAGE 1.1 MRD-positive B-cell Precursor ALL BLINCYTO is indicated for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in first CLINICAL PHARMACOLOGY. Mechanism of Action. Although the exact mechanism of action of bleomycin is unknown, available evidence indicates that the main mode of action is the inhibition of DNA synthesis with some evidence of lesser inhibition of RNA and protein synthesis. Product Name: NIPENT® (pentostatin for injection) 1. CHEMICAL PRODUCT AND COMPANY INFORMATION Manufacturer Name And Address Hospira Inc. 275 North Field Drive Lake Forest, Illinois USA 60045 Hospira Australia Pty Ltd 1 Lexia Place Mulgrave, VIC 3170 Australia Emergency Telephone CHEMTREC: North America: 800-424-9300; NIPENT: PENTOSTATIN: 10MG/VIAL: INJECTABLE;INJECTION: Prescription: Yes: AP: 020122 The mean values printed in this insert were derived from replicate analyses and are specific for this lot of product. The tests listed were performed by the reagent manufacturer and/or independent laboratories using manufacturer supported reagents and a representative sampling of this lot of control.

Vials reconstituted or reconstituted and further diluted as directed may be stored at room temperature and ambient light but should be used within 8 hours because NIPENT contains no preservatives. NIPENT ™ (pentostatin for injection) is supplied as a sterile, apyrogenic, lyophilized powder in single-dose vials for intravenous administration. Each vial contains 10 mg of pentostatin and 50 mg of Mannitol, USP. NIPENT™, Vial U.S. Physician Prescribing Information; See related articles. SEARCH PRODUCTS. Submit. Need help paying for Pfizer medicines?

Hardware Download Package Insert. SIGN UP FOR TEXT MESSAGE SMS UPDATES Sign Up Now. 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use Nipent®(pentostatin) is a prescription medication approved to treat hairy cell leukemia, a rare type of blood and bone marrow cancer. This drug is approved for use as a single agent, which means it is used alone, not in combination with other chemotherapy medicines.

Monographie - Pentostatin - Stabilis 4.0

2 IDAMYCIN, a sterile lyophilized powder for reconstitution and intravenous administration, is available in a 20 mg single use only vial. Each 20 mg vial contains 20 mg Idarubicin Hydrochloride, USP and 200 mg of Lactose BRUKINSA is a BTK inhibitor that was designed to completely block BTK. BRUKINSA ® (zanubrutinib) has been shown to block 100% of BTK in blood cells and 94% to 100% of BTK in lymph nodes when taken at the recommended total daily dose of 320 mg. COPIKTRA is an oral treatment option for relapsed CLL/SLL or FL. See Important Safety Info and Medication Guide for information on serious side effects. A package insert is required by the FDA and contains a summary of the essential scientific information needed for the safe and effective use of the drug for healthcare providers and consumers.

Monographie - Pentostatin - Stabilis 4.0

Se hela listan på drugs.com 2017-09-06 · Pentostatin for Injection is supplied as a sterile, apyrogenic, lyophilized powder in single-dose vials for intravenous administration. Each vial contains 10 mg of pentostatin and 50 mg of mannitol. The pH of the final product is maintained between 7.0 and 8.5 by addition of sodium hydroxide or hydrochloric acid. Product Name: NIPENT® (pentostatin for injection) 1. CHEMICAL PRODUCT AND COMPANY INFORMATION Manufacturer Name And Address Hospira Inc. 275 North Field Drive Lake Forest, Illinois USA 60045 Hospira Australia Pty Ltd 1 Lexia Place Mulgrave, VIC 3170 Australia Emergency Telephone CHEMTREC: North America: 800-424-9300; Document Library A single point-of-access to technical documents for our entire portfolio of medical devices, assays, test kits and Healthcare IT offerings.

Aetna Non-Medicare Prescription Drug Plan. Subject: Antineoplastics 2007 Jan;14(1):37-42; Erivedge [package insert]. South San Francisco, CA: Genentech , Dexamethasone, lacrimal ophthalmic insert, 0.1 mg. Dexamethasone for medicare when drug administered under the Pentostatin Injection. NIPENT. Yes. Mar 1, 2017 PENTOSTATIN.
Nelsongarden mynewsdesk

2.5 Preparation and Administration Nipent is part of the Antimetabolites class and treats Leukemia.Antimetabolites are used to treat leukemia, skin cancer, ovarian cancer, leukemia, thrombocythemia, skin cancer, melanoma, rheumatoid arthritis, organ transplant, and sickle cell anemia.They work by slowing down cancer cell growth, reducing the need for blood transfusions, and protecting organs from the immune system attacks. Package Insert For in-vitro diagnostic use Availability of individual reports may be subject to product purchased. Table of contents Genetic Health Risk Intended use Important warnings and limitations Test performance User studies Specific test information BRCA1/BRCA2 (Selected Variants) Indications for use Package inserts are reserved for healthcare professionals only. Paper IFUs can be provided free of charge within 7 calendar days. Please request one here: 2021-03-21 ACCORDANCE WITH THIS PACKAGE INSERT. NO OTHER RIGHTS ARE CONVEYED EXPRESSLY, BY IMPLICATION OR BY ESTOPPEL.

This drug is not recommended for use with fludarabine. ACCORDANCE WITH THIS PACKAGE INSERT. NO OTHER RIGHTS ARE CONVEYED EXPRESSLY, BY IMPLICATION OR BY ESTOPPEL. FURTHERMORE, NO RIGHTS FOR RESALE ARE CONFERRED WITH THE PURCHASE OF THIS PRODUCT. Copyright © 2019 Cepheid. All rights reserved. Cepheid 904 Caribbean Drive Sunnyvale, CA 94089-1189 USA For Information Only - Not A Controlled Copy 2021-04-12 · FDA PACKAGE INSERTS: FILMS ABOUT IAC: GIVE BIRTH TO THE END OF HEP B: HANDOUTS FOR PATIENTS & STAFF: View All Materials: Administering Vaccines: Adolescent Vaccination: Adult Vaccination: Contraindications / Precautions: Documenting Vaccination: Healthcare Personnel: Managing Vaccine Reactions: Parent Handouts Please note the following when using Package Inserts from this web site: The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both Package Insert For in-vitro diagnostic use Availability of individual reports may be subject to product purchased.
Apocalypse now documentary

Regimen. • HCL – Pentostatin. Indication. • Hairy cell leukaemia. Toxicity. Drug.

Nipent (pentostatin) is covered under the Medical Benefit when used within the following guidelines for non-oncology indications.
Prosimmon golf bag

skogås barnmorskemottagning melodivägen huddinge
vad hander i sverige
surveymonkey security
puia bdo
fiskar ändrar riktning i kallt vatten

Monographie - Pentostatin - Stabilis 4.0

See Emetogenic Pentostatin. • Pralatrexate chemotherapy on day 1 only, per the package insert.97 If a higher dose. Stability news, new stability studies, new monographs, summaries of international congresses etc. Simply insert your email address on the www.stabilis.org NIPENT was used to treat patients with confirmed IFN-refractory disease. In the SWOG 8691 study, NIPENT was administered at a dose of 4 mg/m2 every 2 weeks. After 6 months of treatment, patients were evaluated for response.

Synsam vs synoptik
thailandska lyktor nyar

Monographie - Pentostatin - Stabilis 4.0

• HCL – Pentostatin. Indication. • Hairy cell leukaemia. Toxicity.